Repare Therapeutics Reports Strong 1Q Earnings and Revenue
**Lead:** Repare Therapeutics surprises analysts with a 17% surge in shares after reporting first-quarter earnings that exceeded expectations, showcasing...
cash equivalents
Elevation Oncology Extends Cash Runway, Shares Rise
Lead: Elevation Oncology's stock surges as the company secures funding to extend its cash runway until 2026, despite a...
Celldex Therapeutics Shares Rise 17% After Successful Drug Trial
Lead: Celldex Therapeutics' shares surged 17% to $44.35 after its successful Phase 2 trial for a treatment targeting chronic...
The Pitfalls of Overindulging in Cash
Lead: Investors have been enjoying the high yields of cash equivalents, but advisors warn against overindulging. While cash is...
Senti Biosciences Streamlines Operations to Prioritize Cancer Treatment
Senti Biosciences, a biotech company, is cutting its workforce by 37% to focus on developing a potential treatment for...
Xeris Biopharma Holdings Shares Surge on Raised 2023 Outlook
Shares of Xeris Biopharma Holdings surged 14% to $2.56 after the biopharmaceutical company raised its outlook for 2023. The...